
Overview
Background
Associate Professor West is a molecular microbiologist, expert in bacterial pathogenesis. He is Head of “Tuberculosis Research” in the School of Chemistry and Molecular Biosciences, University of Queensland. Nick has a particular interest in drug development for TB. His research utilises modern molecular technologies to identify the genetic requirements for Mycobacterium tuberculosis to cause Tuberculosis (TB) with these genetic discoveries translated into novel antibiotic therapies. Research within his group falls largely into one of the following four themes: Essential Gene Identification in M. tuberculosis, Understanding TB Latency, Targeted TB Drug Development and Improving TB Vaccination.
Nick conducted postdoctoral research at the University of Oxford and Imperial College London. Returning to Australia in 2004, he spent several years at Sydney’s Centenary Institute as an Associate Faculty member before relocating to University of Queensland in 2012. In addition to drug development, Nick’s research portfolio includes programmes of vaccine and diagnostic development and testing.
Availability
- Professor Nick West is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, University of Wollongong
Works
Search Professor Nick West’s works on UQ eSpace
2013
Journal Article
Host cell-induced components of the sulfate assimilation pathway are major protective antigens of Mycobacterium tuberculosis
Pinto, Rachel, Leotta, Lisa, Shanahan, Erin R., West, Nicholas P., Leyh, Thomas S., Britton, Warwick and Triccas, James A. (2013). Host cell-induced components of the sulfate assimilation pathway are major protective antigens of Mycobacterium tuberculosis. Journal of Infectious Diseases, 207 (5), 778-785. doi: 10.1093/infdis/jis751
2012
Journal Article
Elucidation of Mycobacterium tuberculosis Type II Dehydroquinase Inhibitors using a Fragment Elaboration Strategy
Anh Thu Tran, West, Nicholas P., Britton, Warwick J. and Payne, Richard J. (2012). Elucidation of Mycobacterium tuberculosis Type II Dehydroquinase Inhibitors using a Fragment Elaboration Strategy. Chemmedchem, 7 (6), 1031-1043. doi: 10.1002/cmdc.201100606
2012
Journal Article
The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice
Kao, Fan F., Mahmuda, Sultana, Pinto, Rachel, Triccas, James A., West, Nicholas P. and Britton, Warwick J. (2012). The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice. PLoS One, 7 (5) e34991, e34991. doi: 10.1371/journal.pone.0034991
2012
Journal Article
Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site
Manos-Turvey, Alexandra, Cergol, Katie M., Salam, Noeris K., Bulloch, Esther M. M., Chi, Gamma, Pang, Angel, Britton, Warwick J., West, Nicholas P., Baker, Edward N., Lott, J. Shaun and Payne, Richard J. (2012). Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site. Organic and Biomolecular Chemistry, 10 (46), 9223-9236. doi: 10.1039/c2ob26736e
2011
Journal Article
Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis
West, Nicholas P., Thomson, Scott A., Triccas, James A., Medveczky, C. Jill, Ramshaw, Ian A. and Britton, Warwick J. (2011). Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis. Vaccine, 29 (44), 7759-7765. doi: 10.1016/j.vaccine.2011.07.109
2011
Journal Article
Synthesis and Evaluation of Potent Ene-yne Inhibitors of Type II Dehydroquinases as Tuberculosis Drug Leads
Anh Thu Tran, Cergol, Katie M., West, Nicholas P., Randall, Elizabeth J., Britton, Warwick J., Bokhari, Syed Ali Imran, Ibrahim, Musadiq, Lapthorn, Adrian J. and Payne, Richard J. (2011). Synthesis and Evaluation of Potent Ene-yne Inhibitors of Type II Dehydroquinases as Tuberculosis Drug Leads. Chemmedchem, 6 (2), 262-265. doi: 10.1002/cmdc.201000399
2011
Journal Article
Immunity to mycobacterium tuberculosis
Triccas, James A., Winter, Nathalie, Feng, Carl G. and West, Nicholas P. (2011). Immunity to mycobacterium tuberculosis. Clinical & Developmental Immunology, 2011 (406549) 406549, 1-2. doi: 10.1155/2011/406549
2011
Journal Article
Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads
West, Nicholas P., Cergol, Katie M., Xue, Millie, Randall, Elizabeth J., Britton, Warwick J. and Payne, Richard J. (2011). Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads. Chemical Communications, 47 (18), 5166-5168. doi: 10.1039/c0cc05635a
2010
Journal Article
Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability
Crellin, Paul K., Vivian, Julian P., Scoble, Judith, Chow, Frances M., West, Nicholas P., Brammananth, Rajini, Proellocks, Nicholas I., Shahine, Adam, Le Nours, Jerome, Wilce, Matthew C. J., Britton, Warwick J., Coppel, Ross L., Rossjohn, Jamie and Beddoe, Travis (2010). Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability. Journal of Biological Chemistry, 285 (39), 30050-30060. doi: 10.1074/jbc.M110.150094
2010
Journal Article
Modulation of Shigella virulence in response to available oxygen in vivo
Marteyn, Benoit, West, Nicholas P., Browning, Douglas F., Cole, Jeffery A., Shaw, Jonathan G., Palm, Fredrik, Mounier, Joelle, Prevost, Marie-Christine, Sansonetti, Philippe and Tang, Christoph M. (2010). Modulation of Shigella virulence in response to available oxygen in vivo. Nature, 465 (7296), 355-358+2. doi: 10.1038/nature08970
2010
Journal Article
Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine
Shanahan, Erin R., Pinto, Rachel, Triccas, James A., Britton, Warwick J. and West, Nicholas P. (2010). Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine. Vaccine, 28 (5), 1341-1346. doi: 10.1016/j.vaccine.2009.11.010
2009
Journal Article
Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification
West, Nicholas P., Chow, Frances M. E., Randall, Elizabeth J., Wu, Jing, Chen, Jian, Ribeiro, Jose M. C. and Britton, Warwick J. (2009). Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification. Faseb Journal, 23 (6), 1694-1704. doi: 10.1096/fj.08-114421
2008
Journal Article
Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis
West, Nicholas P., Wozniak, Teresa M., Valenzuela, Jesus, Feng, Carl G., Sher, Alan, Ribeiro, Jose M. C. and Britton, Warwick J. (2008). Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis. Vaccine, 26 (31), 3853-3859. doi: 10.1016/j.vaccine.2008.05.007
2005
Journal Article
Available carbon source influences the resistance of Neisseria meningitidis against complement
Exley, RM, Shaw, J, Mowe, E, Sun, YH, West, NP, Williamson, M, Botto, M, Smith, H and Tang, CM (2005). Available carbon source influences the resistance of Neisseria meningitidis against complement. Journal of Experimental Medicine, 201 (10), 1637-1645. doi: 10.1084/jem.20041548
2005
Journal Article
Optimization of virulence functions through glucosylation of Shigella LPS
West, NP, Sansonetti, P, Mounier, J, Exley, RM, Parsot, C, Guadagnini, S, Prevost, MC, Prochnicka-Chalufour, A, Delepierre, M, Tanguy, M and Tang, CM (2005). Optimization of virulence functions through glucosylation of Shigella LPS. Science, 307 (5713), 1313-1317. doi: 10.1126/science.1108472
2003
Journal Article
Finding your niche: what has been learnt from STM studies on GI colonization
West, NP, Sansonetti, PJ, Frankel, G and Tang, CM (2003). Finding your niche: what has been learnt from STM studies on GI colonization. Trends in Microbiology, 11 (7), 338-344. doi: 10.1016/S0966-842X(03)00154-9
2003
Journal Article
An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection
McArthur, JD, West, NP, Cole, JN, Jungnitz, H, Guzman, CA, Chin, J, Lehrbach, PR, Djordjevic, SP and Walker, MJ (2003). An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection. Fems Microbiology Letters, 221 (1), 7-16. doi: 10.1016/S0378-1097(03)00162-9
2002
Journal Article
High throughput in vivo screens: Signature-tagged mutagenesis
West, N, Sansonetti, P and Tang, CM (2002). High throughput in vivo screens: Signature-tagged mutagenesis. Functional Microbial Genomics, 33, 153-165.
2000
Journal Article
Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence
West, Nicholas P., Jungnitz, Heidrun, Fitter, John T., McArthur, Jason D., Guzman, Carlos A. and Walker, Mark J. (2000). Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infection and Immunity, 68 (8), 4673-4680. doi: 10.1128/IAI.68.8.4673-4680.2000
1998
Journal Article
A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence
Jungnitz, Heidrun, West, Nicholas P., Walker, Mark J., Chhatwal, Gursharan S. and Guzman, Carlos A. (1998). A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence. Infection and Immunity, 66 (10), 4640-4650.
Funding
Current funding
Supervision
Availability
- Professor Nick West is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
A Multidisciplinary Approach to Identifying Novel Vaccine and Drug Targets of Non-Tuberculous Mycobacteria
Principal Advisor
Other advisors: Dr Brian Forde
-
Doctor Philosophy
Boosting BCG: The use of Potent Immunostimulatory Secreted Antigens of Mycobacterium tuberculosis.
Principal Advisor
Other advisors: Dr Emily Strong
-
Doctor Philosophy
Advanced Genetic Toolkit for Cryptococcus neoformans: Iterating Upon Currently Used Techniques in the WHO¿s Top-Ranked Fungal Pathogen
Associate Advisor
Other advisors: Professor James Fraser
Completed supervision
-
2023
Doctor Philosophy
Host-pathogen interactions in tuberculosis: Functional insights into a novel mycobacterial two-component system TcrXY
Principal Advisor
-
2022
Doctor Philosophy
Disseminated Tuberculosis; Defining Pathogen Encoded Mechanisms
Principal Advisor
Other advisors: Professor Mark Walker
-
2017
Doctor Philosophy
A Functional Genomics Approach to Vaccine Development Against Mycobacterium tuberculosis and the Role MmpL13 Plays in Tuberculosis Infection
Principal Advisor
-
2024
Doctor Philosophy
Advanced Genetic Toolkit for Cryptococcus neoformans: Iterating Upon Currently Used Techniques in the WHO's Top-Ranked Fungal Pathogen
Associate Advisor
Other advisors: Professor James Fraser
-
2023
Doctor Philosophy
New Antimicrobial Drug Targets
Associate Advisor
Other advisors: Professor Luke Guddat
-
2019
Doctor Philosophy
Point-of-care tuberculosis diagnostics: Meeting global needs through innovative nanotechnologies
Associate Advisor
Other advisors: Professor Matt Trau
-
2016
Doctor Philosophy
Inhibition of Bacterial 6-Oxopurine Phosphoribosyltransferase as Potential Antibacterial Target
Associate Advisor
Other advisors: Professor Luke Guddat
Media
Enquiries
Contact Professor Nick West directly for media enquiries about:
- TB Drug Development
- TB Vaccine Development
- Tuberculosis (TB)
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: